↓ Skip to main content

Cochrane Database of Systematic Reviews

Single dose oral etoricoxib for acute postoperative pain in adults

Overview of attention for article published in this source, April 2012
Altmetric Badge

Mentioned by

1 policy source
5 tweeters


37 Dimensions

Readers on

35 Mendeley
Single dose oral etoricoxib for acute postoperative pain in adults
Published by
John Wiley & Sons, Ltd, April 2012
DOI 10.1002/14651858.cd004309.pub3
Pubmed ID

Clarke, Rachel, Derry, Sheena, Moore, R Andrew


Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor licensed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis, and acute pain in some jurisdictions. This class of drugs is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs). One additional study in acute postoperative pain has been published since the original review was completed in Issue 2, 2009.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 3%
Brazil 1 3%
Unknown 33 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 20%
Student > Master 5 14%
Researcher 4 11%
Student > Doctoral Student 3 9%
Student > Bachelor 2 6%
Other 7 20%
Unknown 7 20%
Readers by discipline Count As %
Medicine and Dentistry 23 66%
Agricultural and Biological Sciences 1 3%
Nursing and Health Professions 1 3%
Psychology 1 3%
Social Sciences 1 3%
Other 1 3%
Unknown 7 20%